of human complement receptor type 3 (CR3, CD11b/CD18) regulate ligand avidity and the internalization of occupied receptors. J Immunol 1993 Jul 15;151(2):990-1002
gov/pmc/articles/PMC2851844/. ^ “VHS domains of ESCRT-0 cooperate in high-avidity binding to polyubiquitinated cargo”. EMBO J. 29 (6): 1045–54. (March 2010)